Denise Carter - 27 Jan 2025 SCHEDULE 13D/A Report for Quoin Pharmaceuticals Ltd. Ordinary Shares, no par value per share (represented by American Depositary Shares) (QNRX)

Filing Manager: Denise Carter
Reporting Manager: Denise Carter
Security: Quoin Pharmaceuticals Ltd. Ordinary Shares, no par value per share (represented by American Depositary Shares)
Symbol: QNRX
Shares outstanding: 19,168,122 shares
Disclosed Ownership: 939,238 shares
Ownership: 4.9%
Form type: SCHEDULE 13D/A
Filing time: 28 Jan 2025, 16:43:38 UTC
Date of event: 27 Jan 2025
Previous filing: 02 Jan 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Denise Carter	4.9%	939,238	939,238	0	/s/ Denise Carter	Denise Carter	0001958621